LAT Gene

Last updated on: 13.03.2022

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

LAT (LAT stands for "Linker For Activation Of T Cells") is a protein-coding gene located on chromosome 16q13. The protein encoded by this gene is phosphorylated by ZAP-70/Syk protein tyrosine kinases after activation of the T cell antigen receptor (TCR) signaling pathway.

General informationThis section has been translated automatically.

The LAT transmembrane protein localizes to "lipid rafts" and functions as a docking site for SH2 domain-containing proteins. Upon phosphorylation, this protein recruits multiple adaptor proteins and downstream signaling molecules into multimolecular signaling complexes located near the TCR binding site.The protein is involved in FCGR3 (low affinity immunoglobulin gamma Fc region receptor III)-mediated signaling in natural killer cells and FCER1 (high affinity immunoglobulin epsilon receptor)-mediated signaling in mast cells. Couples activation of these receptors and their associated kinases with distal intracellular events such as mobilization of intracellular calcium stores.

Disease: Diseases associated with LAT include: Immunodeficiency 52 (OMIM: 617514).

LiteratureThis section has been translated automatically.

  1. Bacchelli C et al. (2017) Mutations in linker for activation of T cells (LAT) lead to a novel form of severe combined immunodeficiency. J Allergy Clin Immun 139: 634-642.
  2. Keller B et al (2016) Early onset combined immunodeficiency and autoimmunity in patients with loss-of-function mutation in LAT. J Exp Med 213: 1185-1199.
  3. Sommers CL et al (2002) LAT mutation that inhibits T cell development yet induces lymphoproliferation. Science 296: 2040-2043.

Last updated on: 13.03.2022